BOSTON (Reuters) - Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse. Latisse is designed to treat a ...
We know D.C. Get our free newsletter to stay in the know. Who does Latisse hire to demonstrate the condition of having “not-enough” hair? Brooke Shields, an actress with a flowing mane, famously ample ...
Latisse, the prescription drug that's taking eyelashes to new lengths, is one of the hottest new cosmetic trends. It promises fringe benefits of longer, fuller, darker lashes. But those long lashes ...
It's normal to lose a few eyelashes a day, but if you notice them constantly falling out, it could be a medical condition.
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." "Eyelash growth serums and lash conditioners may help strengthen lashes, prevent them from breaking, or ...
Latisse: potential to more than double sales with approval for hair loss Irvine-based Allergan Inc. is aiming for a market worth about $1 billion a year in sales as it moves along with the development ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A glaucoma drug that has been on the market for years has been approved ...
Rosemary Abendroth sums up the problem in two words: eyelash envy. “I’m a blonde and when you’re a blonde you always wish for longer, thicker, blacker lashes,” says the PR director from Manhattan.
When an eyelash growth product called Lavish Lash became an Amazon best seller in 2017, a flood of customers promptly wrote to ask: Can I use this on my eyebrows? Answer: Yes. But then, inevitably, ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Long luscious lashes are always the goal in any makeup routine, and there’s one category of product that ...
If you have short eyelashes,a possible solution: a new medicine that makes them grow longer and thicker, Dr Bruce Hensel reported. "Sounds great, but there may be some downsides. This drug is ...